Canakinumab Subcutaneous and Diuril Injection
Determining the interaction of Canakinumab Subcutaneous and Diuril Injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: canakinumab
Brand name: Ilaris
Synonyms: Canakinumab
Generic Name: chlorothiazide
Brand name: Diuril, Diuril Sodium
Synonyms: Chlorothiazide (oral/injection), Chlorothiazide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Canakinumab Subcutaneous-Diuril oral/injection
- Canakinumab Subcutaneous-Diuril Sodium
- Canakinumab Subcutaneous-Divalproex
- Canakinumab Subcutaneous-Divalproex Capsules
- Canakinumab Subcutaneous-Divalproex Delayed Release
- Canakinumab Subcutaneous-Divalproex Delayed Release Tablets
- Diuril Injection-Canasa
- Diuril Injection-Canasa Pac rectal
- Diuril Injection-Canasa rectal
- Diuril Injection-Cancidas
- Diuril Injection-Candesartan
- Diuril Injection-Candesartan and Hydrochlorothiazide